{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-23-000037","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.655448+00:00","generated_at":"2026-06-15T09:45:00.200876+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clover Health Q1 2023 Insurance MCR improves to 86.6%, raises FY guidance","bullets":["Insurance revenue $317.1M (+14% YoY); Insurance MCR improved 980 bps to 86.6% from 96.4%.","Net loss $72.6M vs $75.5M Q1 2022; Adjusted EBITDA $(30.5)M, improvement of $40.4M YoY.","FY 2023 guidance raised: Insurance MCR 87%-89% (prior 88%-91%), revenue $1.18B-$1.23B, Adj. EBITDA ($125M)-($175M).","Non-Insurance revenue $205.8M (-65% as planned); Non-Insurance MCR improved to 96.1% from 99.8%."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-23-000037","json":"https://secwatch.observer/filing/0001801170-23-000037.json","markdown":"https://secwatch.observer/filing/0001801170-23-000037.md","text":"https://secwatch.observer/filing/0001801170-23-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000037/0001801170-23-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000037/clov-20230509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T09:45:00.200876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e011b6327be4a3ebb5f2c4d502d926df05812e5d","claim":"CLOVER HEALTH INVESTMENTS, CORP. /DE reported the first quarter 2023 results: revenue $527.8 million, net income net loss of $72.6 million. Guidance raised.","evidence_excerpt":"For the first quarter 2023, the Company reported revenue of $527.8 million and net loss of $72.6 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000037/0001801170-23-000037-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter 2023"},{"label":"Revenue","value":"$527.8 million"},{"label":"Net income","value":"net loss of $72.6 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e0f7e7766bb37d5b1141d14a1c705627f3fcf462","claim":"CLOVER HEALTH INVESTMENTS, CORP. /DE reported full year 2023 results: revenue Insurance revenue of $1.18 billion - $1.23 billion. Guidance raised.","evidence_excerpt":"Improved 2023 guidance includes Insurance MCR of 87% - 89%, Insurance revenue of $1.18 billion - $1.23 billion, and Adjusted EBITDA of ($125) million - ($175) million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000037/0001801170-23-000037-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"Revenue","value":"Insurance revenue of $1.18 billion - $1.23 billion"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}